Mabdx

Eugene, OR

UEI
ENL2DAEMVRX5
CAGE
6PXM2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
389 Dellwood Dr, Eugene, OR 97405, USA
Website
mabdx.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Simultaneous diagnosis of dengue and prognosis of severe dengue with a single point-of-care test - dengue is the most… R43AI162484 National Institute of Allergy and Infectious Diseases (NIH) $1,499,811
Novel, simple and rapid point-of-care lateral flow immunoassays for diagnosis of zika virus infection R43AI132041 National Institute of Allergy and Infectious Diseases (NIH) $300,000
Diagnostic tools for managing vibriosis in marine shellfish hatcheries 201433610219261 National Institute of Food and Agriculture $100,000

Quick answers

Is Mabdx registered in SAM.gov?

Yes. Mabdx's SAM.gov registration is active through December 16, 2026.

What is Mabdx's most recent federal award?

Mabdx's most recent federal grant award is Simultaneous diagnosis of dengue and prognosis of severe dengue with a single point-of-care test - dengue is the most… (R43AI162484), from National Institute of Allergy and Infectious Diseases (NIH), on August 25, 2021.

On GovTribe

See Mabdx's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login